Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091 [Phase 1]
This Phase 1 study assesses how BI-754111 is distributed in patients with advanced non-small cell lung cancer or head and neck cancer who ar…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: A Study of XL184 (Cabozantinib) With or Without Erlotinib in Subjects With Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluated cabozantinib (XL184) with or without erlotinib in non-small cell lung cancer, and results hav…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation [Phase 1, Phase 2]
The Phase 1/2 study of JAB-21822 in adults with KRAS G12C-mutant advanced solid tumors, including non-small cell lung cancer and colorectal …
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Retifanlimab and Ruxolitinib In Solid Malignancies [Phase 1, Phase 2]
A Phase 1/2 trial of retifanlimab and ruxolitinib in solid malignancies is currently recruiting, including non-small cell lung cancer and re…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Electro-Acupuncture in Lung cancER : EALER Study [NA]
Clinical trial update for the Electro-Acupuncture in Lung Cancer (EALER Study) investigating acupuncture in non-small cell lung cancer; the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for DECOY20 with or without tislelizumab in adults with advanced solid tumors across Phase 1 and Phase 2. The listed i…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Study of SGN-MesoC2 in Advanced Solid Tumors [Phase 1]
Seagen is conducting a Phase 1 study of SGN-MesoC2 in advanced solid tumors, including non-small cell lung cancer, ovarian cancer, pancreati…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers [Phase 1, Phase 2]
A Phase 1/2 study of OC-001 in locally advanced or metastatic cancers has been terminated according to its clinical trials registry listing.
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery [Phase 2]
This clinical trial update describes a Phase 2 study evaluating whether adding fianlimab to cemiplimab and chemotherapy improves safety and …
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Osimertinib Plus Chemotherapy vs Osimertinib in EGFRm NSCLC With Persistence Week-3 ctDNA EGFRm After 1L Osimertinib [Phase 2]
Phase 2 trial update comparing osimertinib plus chemotherapy versus osimertinib alone in EGFR-mutant non-small cell lung cancer with persist…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC [Phase 3]
This document describes an ongoing Phase 3 trial evaluating THIO plus cemiplimab versus chemotherapy as third-line treatment for advanced/me…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating TJ101 for safety, pharmacokinetics, and efficacy in advanced/metastatic solid tumors, including non-small …
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Study of ONO-7428 in Participants With Unresectable Advanced or Recurrent Solid Tumors [Phase 1]
Phase 1 clinical trial update for ONO-7428 in participants with unresectable advanced or recurrent solid tumors, including non-small cell lu…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: 125I Seed Implantation Plus Systemic Therapy for Oligoprogressive NSCLC or Colorectal Cancer [Phase 2]
Phase 2 clinical trial update on 125I seed implantation plus systemic therapy for oligoprogressive non-small cell lung cancer or colorectal …
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Avutometinib (VS-6766) with Sotorasib, with or without Defactinib, in KRAS G12C NSCLC; currently active …
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Efficacy and Safety of 80mg Osimertinib in Patients With Non-small Cell Lung Cancer(NSCLC) [Phase 2]
A Phase 2 trial evaluating 80 mg osimertinib in patients with non-small cell lung cancer has completed, reporting on efficacy and safety. Th…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors [Phase 1, Phase 2]
A first-in-human Phase 1/2 trial of JAB-8263 in adults with advanced tumors is currently recruiting across multiple cancer types including l…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Tislelizumab Combined With Thoracic Radiotherapy as Neoadjuvant Therapy for Resectable NSCLC [Phase 2]
A Phase 2 clinical trial investigating tislelizumab in combination with thoracic radiotherapy as neoadjuvant therapy for resectable non-smal…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors [Phase 1]
Phase 1 study of Felmetatug Vedotin (SGN-B7H4V) in advanced solid tumors was terminated.
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Phase II Study of Sacituzumab Tirumotecan in Combination With Osimertinib or Sacituzumab Tirumotecan for Neoadjuvant Treatment in Patients With Resectable Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer [Phase 2]
Phase II neoadjuvant trial evaluating Sacituzumab Tirumotecan in combination with Osimertinib or Sacituzumab Tirumotecan alone for resectabl…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: QL1706 Combined With Chemotherapy in the Treatment of Immune-mediated NSCLC [Phase 2]
A Phase 2 trial evaluating QL1706 in combination with chemotherapy for advanced immune-mediated non-small cell lung cancer is currently recr…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: WAST Cell-Docetaxel Combination Therapy in PD-1 Inhibitor-Resistant Advanced NSCLC [Phase 2]
Phase 2 clinical trial evaluating WAST Cell in combination with docetaxel for PD-1 inhibitor-resistant advanced non-small cell lung cancer; …
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Iruplinalkib Tablets as Postoperative Adjuvant Therapy in Stage IA ALK-positive NSCLC With High-risk Factors [Phase 2]
A Phase 2 clinical trial is investigating iruplinalkib tablets as postoperative adjuvant therapy for Stage IA ALK-positive non-small cell lu…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Dyadic Yoga Program for Patients Undergoing Thoracic Radiotherapy and Their Family Caregivers: The Testing of a Mobile Application Delivery [NA]
A clinical trial is testing a mobile app-delivered dyadic yoga program for patients with non-small cell lung cancer undergoing thoracic radi…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
LOTUS-CC is an observational study at the University of Rochester aimed at uncovering subtypes of cancer cachexia in patients with advanced …